Theravance Biopharma, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2013 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Theravance Biopharma, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2013 to Q3 2024.
  • Theravance Biopharma, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 49.2M shares, a 3.24% decline year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 49.2M -1.65M -3.24% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 48.9M -4.77M -8.89% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 48.6M -12M -19.8% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 48.1M -17.1M -26.3% Dec 31, 2023 10-Q 2024-11-14
Q3 2023 50.8M -16.5M -24.6% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 53.7M -22.7M -29.7% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 60.5M -15.5M -20.4% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 65.2M -9.21M -12.4% Dec 31, 2022 10-K 2024-03-01
Q3 2022 67.4M -6.33M -8.59% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 76.4M +2.96M +4.03% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 76.1M +10.9M +16.7% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 74.4M +10.1M +15.7% Dec 31, 2021 10-K 2023-03-01
Q3 2021 73.7M +9.74M +15.2% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 73.5M +9.96M +15.7% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 65.2M +2.21M +3.51% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 64.3M +7.31M +12.8% Dec 31, 2020 10-K 2022-02-28
Q3 2020 64M +7.19M +12.7% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 63.5M +6.88M +12.1% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 63M +6.88M +12.3% Mar 31, 2020 10-Q 2020-05-08
Q4 2019 57M +1.33M +2.4% Dec 31, 2019 10-K 2021-02-26
Q3 2019 56.8M +1.35M +2.44% Sep 30, 2019 10-Q 2019-11-08
Q2 2019 56.6M +1.53M +2.78% Jun 30, 2019 10-Q 2019-08-05
Q1 2019 56.1M +1.32M +2.42% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 55.7M +1.3M +2.39% Dec 31, 2018 10-K 2020-02-27
Q3 2018 55.4M +1.32M +2.45% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 55.1M +1.28M +2.37% Jun 30, 2018 10-Q 2018-08-02
Q1 2018 54.8M +1.51M +2.83% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 54.4M +1.55M +2.93% Dec 31, 2017 10-K 2019-02-28
Q3 2017 54.1M +6M +12.5% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 53.8M +5.98M +12.5% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 53.3M +11.8M +28.6% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 52.8M +14.9M +39.1% Dec 31, 2016 10-K 2018-02-28
Q3 2016 48.1M +14.2M +41.7% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 47.9M +13.9M +41% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 41.5M +7.65M +22.6% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 38M +5.76M +17.9% Dec 31, 2015 10-K 2017-03-01
Q3 2015 33.9M +1.71M +5.3% Sep 30, 2015 10-Q 2015-11-12
Q2 2015 33.9M +1.68M +5.21% Jun 30, 2015 10-Q 2015-08-13
Q1 2015 33.8M Mar 31, 2015 10-Q 2015-05-13
Q4 2014 32.2M +32.2M Dec 31, 2014 10-K 2016-03-11
Q3 2014 32.2M Sep 30, 2014 10-Q 2014-11-12
Q2 2014 32.3M Jun 30, 2014 10-Q 2014-08-14
Q4 2013 0 Dec 31, 2013 10-K 2015-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.